Inactive ingredients
This article was originally published in The Tan Sheet
Executive Summary
FDA considering allowing additional public comment for provisions on the labeling of inactive ingredients in its pending final rule on OTC label reform, the agency announces in an updated guidance on OTC ingredient listings. The document clarifies FDA's implementation plans for provisions of the FDA Modernization Act dealing with active and inactive ingredients. A draft of the guidance was inadvertently published in the April 9 Federal Register ("The Tan Sheet" Feb. 23, p. 4). The new version is available on the agency's Web site (www.fda.gov)...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning